Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity.
Vaccines (Basel).
2022 Nov 1;10(11). doi: 10.3390/vaccines10111856. PubMed PMID:
36366364; PubMed Central PMCID:
PMC9694415.
Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection.
Sci Rep.
2022 Sep 2;12(1):14971. doi: 10.1038/s41598-022-18977-0. PubMed PMID:
36056075; PubMed Central PMCID:
PMC9440095.
Aberrant Cellular Glycosylation May Increase the Ability of Influenza Viruses to Escape Host Immune Responses through Modification of the Viral Glycome.
mBio.
2022 Apr 26;13(2):e0298321. doi: 10.1128/mbio.02983-21. Epub 2022 Mar 14. PubMed PMID:
35285699; PubMed Central PMCID:
PMC9040841.
Immune-mediated attenuation of influenza illness after infection: opportunities and challenges.
Lancet Microbe.
2021 Dec;2(12):e715-e725. doi: 10.1016/S2666-5247(21)00180-4. Epub 2021 Sep 24. Review. PubMed PMID:
35544110.
Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets.
NPJ Vaccines.
2019;4:28. doi: 10.1038/s41541-019-0123-7. eCollection 2019. PubMed PMID:
31312528; PubMed Central PMCID:
PMC6616337.
Influenza virus N-linked glycosylation and innate immunity.
Biosci Rep.
2019 Jan 31;39(1). doi: 10.1042/BSR20171505. Print 2019 Jan 31. Review. PubMed PMID:
30552137; PubMed Central PMCID:
PMC6328934.
Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
Vaccine.
2018 Oct 29;36(45):6744-6751. doi: 10.1016/j.vaccine.2018.09.031. Epub 2018 Sep 25. PubMed PMID:
30266488; PubMed Central PMCID:
PMC6200586.
Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses After Influenza Vaccination in Adults.
J Infect Dis.
2018 Oct 5;218(10):1571-1581. doi: 10.1093/infdis/jiy376. PubMed PMID:
29931203; PubMed Central PMCID:
PMC8974399.
Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus.
J Immunol Methods.
2018 Oct;461:23-29. doi: 10.1016/j.jim.2018.07.007. Epub 2018 Jul 24. Review. PubMed PMID:
30053389; PubMed Central PMCID:
PMC6416777.
A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose.
Mol Ther Methods Clin Dev.
2018 Sep 21;10:210-222. doi: 10.1016/j.omtm.2018.07.007. eCollection 2018 Sep 21. PubMed PMID:
30101154; PubMed Central PMCID:
PMC6082999.
Virulent PB1-F2 residues: effects on fitness of H1N1 influenza A virus in mice and changes during evolution of human influenza A viruses.
Sci Rep.
2018 May 10;8(1):7474. doi: 10.1038/s41598-018-25707-y. PubMed PMID:
29749408; PubMed Central PMCID:
PMC5945659.
Extensive T cell cross-reactivity between diverse seasonal influenza strains in the ferret model.
Sci Rep.
2018 Apr 17;8(1):6112. doi: 10.1038/s41598-018-24394-z. PubMed PMID:
29666412; PubMed Central PMCID:
PMC5904180.
Evolution and Virulence of Influenza A Virus Protein PB1-F2.
Int J Mol Sci.
2017 Dec 29;19(1). doi: 10.3390/ijms19010096. Review. PubMed PMID:
29286299; PubMed Central PMCID:
PMC5796046.
An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.
Virology.
2017 Nov;511:214-221. doi: 10.1016/j.virol.2017.08.016. Epub 2017 Sep 6. PubMed PMID:
28888111; PubMed Central PMCID:
PMC5727915.
Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
J Virol.
2017 Oct 15;91(20). doi: 10.1128/JVI.01202-17. Print 2017 Oct 15. PubMed PMID:
28768855; PubMed Central PMCID:
PMC5625511.
Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
PLoS One.
2017;12(10):e0186244. doi: 10.1371/journal.pone.0186244. eCollection 2017. PubMed PMID:
29023601; PubMed Central PMCID:
PMC5638338.
Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
Virology.
2017 Aug;508:164-169. doi: 10.1016/j.virol.2017.05.010. Epub 2017 May 26. PubMed PMID:
28554058; PubMed Central PMCID:
PMC5788307.
Influenza virus exploits tunneling nanotubes for cell-to-cell spread.
Sci Rep.
2017 Jan 6;7:40360. doi: 10.1038/srep40360. PubMed PMID:
28059146; PubMed Central PMCID:
PMC5216422.
Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.
Sci Rep.
2016 Nov 16;6:37341. doi: 10.1038/srep37341. PubMed PMID:
27849030; PubMed Central PMCID:
PMC5110975.
An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.
Antiviral Res.
2016 Nov;135:48-55. doi: 10.1016/j.antiviral.2016.10.001. Epub 2016 Oct 3. PubMed PMID:
27713074; PubMed Central PMCID:
PMC5729279.
Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence.
Sci Rep.
2016 Oct 31;6:36216. doi: 10.1038/srep36216. PubMed PMID:
27796371; PubMed Central PMCID:
PMC5086918.
Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus.
PLoS One.
2016;11(6):e0157903. doi: 10.1371/journal.pone.0157903. eCollection 2016. PubMed PMID:
27315117; PubMed Central PMCID:
PMC4912066.
RIG-I ligand enhances the immunogenicity of recombinant H7HA protein.
Cell Immunol.
2016 Jun-Jul;304-305:55-8. doi: 10.1016/j.cellimm.2016.04.004. Epub 2016 Apr 9. PubMed PMID:
27106062; PubMed Central PMCID:
PMC5240151.
Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans.
Open Forum Infect Dis.
2016 Apr;3(2):ofw102. doi: 10.1093/ofid/ofw102. eCollection 2016 Apr. PubMed PMID:
27419174; PubMed Central PMCID:
PMC4943536.
A highly immunogenic vaccine against A/H7N9 influenza virus.
Vaccine.
2016 Feb 3;34(6):744-9. doi: 10.1016/j.vaccine.2015.12.062. Epub 2016 Jan 4. PubMed PMID:
26765287; PubMed Central PMCID:
PMC4735641.
Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets.
Vaccine.
2016 Jan 20;34(4):466-473. doi: 10.1016/j.vaccine.2015.12.023. Epub 2015 Dec 19. PubMed PMID:
26709639; PubMed Central PMCID:
PMC4713238.
Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.
Virology.
2015 Nov;485:252-62. doi: 10.1016/j.virol.2015.08.004. Epub 2015 Aug 27. PubMed PMID:
26318247; PubMed Central PMCID:
PMC5737639.
Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice.
J Virol.
2015 Jun;89(11):5835-46. doi: 10.1128/JVI.03137-14. Epub 2015 Mar 18. PubMed PMID:
25787281; PubMed Central PMCID:
PMC4442455.
An MHC class I immune evasion gene of Marek׳s disease virus.
Virology.
2015 Jan 15;475:88-95. doi: 10.1016/j.virol.2014.11.008. Epub 2014 Nov 27. PubMed PMID:
25462349; PubMed Central PMCID:
PMC4280340.
Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers.
PLoS One.
2014;9(11):e111603. doi: 10.1371/journal.pone.0111603. eCollection 2014. PubMed PMID:
25368997; PubMed Central PMCID:
PMC4219726.
Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.
Influenza Other Respir Viruses.
2014 Nov;8(6):628-35. doi: 10.1111/irv.12285. Epub 2014 Sep 12. PubMed PMID:
25213778; PubMed Central PMCID:
PMC4262278.
Influenza vaccination accelerates recovery of ferrets from lymphopenia.
PLoS One.
2014;9(6):e100926. doi: 10.1371/journal.pone.0100926. eCollection 2014. PubMed PMID:
24968319; PubMed Central PMCID:
PMC4072694.
Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.
Virology.
2014 Jun;458-459:114-24. doi: 10.1016/j.virol.2014.04.011. Epub 2014 May 10. PubMed PMID:
24928044; PubMed Central PMCID:
PMC4904151.
LABEL: fast and accurate lineage assignment with assessment of H5N1 and H9N2 influenza A hemagglutinins.
PLoS One.
2014;9(1):e86921. doi: 10.1371/journal.pone.0086921. eCollection 2014. PubMed PMID:
24466291; PubMed Central PMCID:
PMC3900692.
Molecular determinants of influenza virus pathogenesis in mice.
Curr Top Microbiol Immunol.
2014;385:243-74. doi: 10.1007/82_2014_388. Review. PubMed PMID:
25038937; PubMed Central PMCID:
PMC4618372.
Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.
Autoimmunity.
2013 Dec;46(8):497-508. doi: 10.3109/08916934.2013.819855. Epub 2013 Sep 13. PubMed PMID:
24028501; PubMed Central PMCID:
PMC4104477.
The 2009 pandemic influenza virus: where did it come from, where is it now, and where is it going?.
Curr Top Microbiol Immunol.
2013;370:241-57. doi: 10.1007/82_2012_221. Review. PubMed PMID:
22638836.
Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010.
Virology.
2012 Oct 25;432(2):405-16. doi: 10.1016/j.virol.2012.06.021. Epub 2012 Jul 20. PubMed PMID:
22818871.
A distinct lineage of influenza A virus from bats.
Proc Natl Acad Sci U S A.
2012 Mar 13;109(11):4269-74. doi: 10.1073/pnas.1116200109. Epub 2012 Feb 27. PubMed PMID:
22371588; PubMed Central PMCID:
PMC3306675.
Mice completely lacking immunoproteasomes show major changes in antigen presentation.
Nat Immunol.
2011 Dec 25;13(2):129-35. doi: 10.1038/ni.2203. PubMed PMID:
22197977; PubMed Central PMCID:
PMC3262888.
Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.
Clin Vaccine Immunol.
2011 Dec;18(12):2010-7. doi: 10.1128/CVI.05206-11. Epub 2011 Oct 26. PubMed PMID:
22030367; PubMed Central PMCID:
PMC3232700.
Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.
PLoS One.
2011;6(10):e25333. doi: 10.1371/journal.pone.0025333. Epub 2011 Oct 21. PubMed PMID:
22031815; PubMed Central PMCID:
PMC3198734.
The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins.
J Virol.
2011 Jul;85(14):7048-58. doi: 10.1128/JVI.00417-11. Epub 2011 May 18. PubMed PMID:
21593152; PubMed Central PMCID:
PMC3126612.
Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1.
Nat Struct Mol Biol.
2011 May;18(5):604-13. doi: 10.1038/nsmb.2021. Epub 2011 Apr 10. PubMed PMID:
21478864; PubMed Central PMCID:
PMC3087843.
Cutting Edge: Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme.
J Immunol.
2011 Feb 15;186(4):1909-13. doi: 10.4049/jimmunol.1003337. Epub 2011 Jan 17. PubMed PMID:
21242517; PubMed Central PMCID:
PMC4039038.
Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
J Virol.
2010 Sep;84(17):8561-70. doi: 10.1128/JVI.00960-10. Epub 2010 Jun 30. PubMed PMID:
20592083; PubMed Central PMCID:
PMC2919012.
Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1.
J Immunol.
2010 Aug 1;185(3):1584-92. doi: 10.4049/jimmunol.0902502. Epub 2010 Jun 30. PubMed PMID:
20592285; PubMed Central PMCID:
PMC2910840.
Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.
J Virol.
2010 Jun;84(11):5741-50. doi: 10.1128/JVI.00079-10. Epub 2010 Mar 24. PubMed PMID:
20335268; PubMed Central PMCID:
PMC2876610.
Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation.
J Immunol.
2010 May 1;184(9):4725-32. doi: 10.4049/jimmunol.0903125. Epub 2010 Mar 29. PubMed PMID:
20351195; PubMed Central PMCID:
PMC2858786.
Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo.
J Immunol.
2009 Nov 15;183(10):6069-77. doi: 10.4049/jimmunol.0803564. Epub 2009 Oct 19. PubMed PMID:
19841172; PubMed Central PMCID:
PMC4314709.
What would you like to do?